Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-04

FDA Approved: FAMCICLOVIR — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for Apotex Corp. to market a generic version of famciclovir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famciclovir (famciclovir)

Snippet

SUPPL AP for FAMCICLOVIR (FAMCICLOVIR)